Viraleze (astodrimer intranasal) / Starpharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Viraleze (astodrimer intranasal) / Starpharma
ACTRN12620001371987: A randomized, double-blind, placebo-controlled investigation of the safety, tolerability and pharmacokinetics of 1% SPL7013 nasal spray in healthy volunteers when administered four times a day for 14 days

Completed
1
40
 
Starpharma Pty Ltd, Starpharma Pty Ltd
COVID-19
 
 

Download Options